Merck & Co., Inc. (MRK)
150.72
-1.83
(-1.20%)
USD |
NYSE |
Aug 24, 16:00
151.39
+0.67
(+0.44%)
After-Hours: 19:57
Merck Total Liabilities (Quarterly) : 87.82B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.82B |
| March 31, 2026 | 82.75B |
| December 31, 2025 | 84.20B |
| September 30, 2025 | 77.64B |
| June 30, 2025 | 68.46B |
| March 31, 2025 | 66.72B |
| December 31, 2024 | 70.73B |
| September 30, 2024 | 72.97B |
| June 30, 2024 | 68.98B |
| March 31, 2024 | 65.42B |
| December 31, 2023 | 69.04B |
| September 30, 2023 | 65.43B |
| June 30, 2023 | 65.73B |
| March 31, 2023 | 60.89B |
| December 31, 2022 | 63.10B |
| September 30, 2022 | 62.56B |
| June 30, 2022 | 63.78B |
| March 31, 2022 | 65.72B |
| December 31, 2021 | 67.44B |
| September 30, 2021 | 57.63B |
| June 30, 2021 | 57.30B |
| March 31, 2021 | 63.81B |
| December 31, 2020 | 66.18B |
| September 30, 2020 | 60.53B |
| June 30, 2020 | 62.87B |
| Date | Value |
|---|---|
| March 31, 2020 | 58.61B |
| December 31, 2019 | 58.40B |
| September 30, 2019 | 56.41B |
| June 30, 2019 | 56.23B |
| March 31, 2019 | 54.68B |
| December 31, 2018 | 55.76B |
| September 30, 2018 | 52.47B |
| June 30, 2018 | 52.27B |
| March 31, 2018 | 52.14B |
| December 31, 2017 | 53.30B |
| September 30, 2017 | 53.18B |
| June 30, 2017 | 53.09B |
| March 31, 2017 | 56.47B |
| December 31, 2016 | 55.07B |
| September 30, 2016 | 54.38B |
| June 30, 2016 | 53.03B |
| March 31, 2016 | 54.85B |
| December 31, 2015 | 57.01B |
| September 30, 2015 | 55.55B |
| June 30, 2015 | 55.94B |
| March 31, 2015 | 60.43B |
| December 31, 2014 | 49.54B |
| September 30, 2014 | 56.45B |
| June 30, 2014 | 49.34B |
| March 31, 2014 | 55.90B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
| Pfizer Inc. | 115.64B |
| Bristol Myers Squibb Co. | 65.32B |
| Abbott Laboratories | 57.45B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 129.80B |
| Shareholders Equity (Quarterly) | 41.93B |
| Debt to Equity Ratio | 1.286 |
| Current Ratio | 1.323 |
| Net Debt Paydown Yield | -1.20% |